News in brief: Cann completes NAB settlement; Bioxyne releases GMP-certified MDMA capsules by Adam Sheldon November 11, 2025February 21, 2026 Cann Group has completed its refinancing agreement with National Australia Bank (NAB), marking the conclusion of […]
Emyria inks deal to study MDMA-assisted therapy for first responders by Martin Lane April 3, 2024July 16, 2024
Emyria S3 CBD trial ‘on hold’ as firm stresses need to focus on revenue by Steve Jones February 7, 2024February 7, 2024
Vitura JV to take delivery of first batch of psychedelic medicines by cannabiz team July 26, 2023April 30, 2024
Emyria shares take a hit as company raises another A$2.5 million by Steve Jones May 1, 2023April 30, 2024
Emyria and LGP shares soar after TGA approves limited access to MDMA and psilocybin by Steve Jones February 6, 2023April 29, 2024
Emyria posts A$7m loss but insists 2023 will be ‘momentous’ by Steve Jones August 30, 2022April 29, 2024
Emyria losses deepen as drug development takes centre stage by Steve Jones March 1, 2022April 29, 2024
